Agilent Life Sciences Revenues Rise 28 Percent on Strong China, India Sales

Company officials attributed the spike in life science sales, which include Agilent's mass spectrometry and microarray product lines, to increased demand from emerging Asian markets.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.